SENSEX NIFTY

Drugs

Nov 28, 2014 at 19:47 | Source: CNBC-TV18
Merck is also adding newer products to cater to the growing demand of the Indian market, which is also one of the fastest growing markets for the company.
Nov 26, 2014 at 14:34 | Source: PTI
Ranbaxy Laboratories had sued USFDA over revoking an approval to sell generic versions of Nexium and Valcyte in the US market.
Nov 26, 2014 at 13:38 | Source: CNBC-TV18
The Vizag plant, which manufactures active pharmaceutical ingredient (API) and bulk drugs, was visited by the US Food and Drug Administration last week.
Nov 26, 2014 at 12:26 | Source: Moneycontrol.com
Aurobindo Pharma USA said it had not received any reports of patient complications, but said it had has received four complaints for empty capsules
Nov 25, 2014 at 19:19 | Source: PTI
The company said it has not received any reports of adverse events related to this recall to date, but has received four complaints for empty capsules.
Nov 25, 2014 at 18:50 | Source: PTI
"The decision to import and the country of origin for such imports are based on economic considerations, Kumar said.
Nov 24, 2014 at 16:00 | Source: Firstpost.com
Given this mindless hostility of all Tamil parties to anything Sri Lankan, it is a laughable claim that they could have gotten any concession on the fishermens conviction with Rajapakse.
Nov 18, 2014 at 19:39 | Source: CNBC-TV18
USFDA had revoked tentative approvals granted to Ranbaxy for generic versions of two drugs - AstraZeneca's heartburn drug Nexium & Roche's antiviral drug Valcyte.
Nov 18, 2014 at 14:55 | Source: Reuters
In the suit filed in the District Court for the District of Columbia, Ranbaxy said the FDA's move violated constitutional rights, exceeded the agency's statutory authority, and was "arbitrary, capricious, and otherwise contrary to law."
Nov 14, 2014 at 19:17 | Source: CNBC-TV18
Drug makers Sun Pharma and Merck may be heading to terminate their branded generics joint venture for emerging markets, reports Archana Shukla quoting sources.
Messages on Drugs »

maximindia

Platinum Member

594 Followers

Ranbaxy Labs  

If one notice everyday USA approving many indian co`s formulation in many blockbuster drugs and naturally RBaxy and SUN is in t top of lists.Reasoning is not far to see that USA want Modi`s visit of USA become highflier and what make SUN/RBaxy combo approvals as forerunners as SUN is based

4.53 PM Jul 8th

Market Statistician

Platinum Member

10998 Followers

Mangalam Drugs  

Mangalam Drugs & Organics has touched a 52-week high of Rs 10.25. At 15:13 hrs, the share was quoting at Rs 10.19, up Rs 0.27, or 2.72%. See more

3.15 PM Jul 8th

Market Statistician

Platinum Member

10998 Followers

Aarey Drugs  

At 15:13 hrs, Aarey Drugs and Pharmaceuticals was trading at Rs 21.40 up 7.65%, with a huge increase in its volume of shares traded. Till now over 367,096 shares were traded as compared to its 5-day average of 114,854 shares.

3.15 PM Jul 8th

Market Statistician

Platinum Member

10998 Followers

Parenteral Drug  

At 15:14 hrs, Parenteral Drugs (India) was trading at Rs 33.80 up 4.32%, with a huge increase in its volume of shares traded. Till now over 448,621 shares were traded as compared to its 5-day average of 90,823 shares.

3.15 PM Jul 8th

Market Statistician

Platinum Member

10998 Followers

Mangalam Drugs  

Mangalam Drugs & Organics has touched a 52-week high of Rs 10.21. At 14:14 hrs, the share was quoting at Rs 10.25, up Rs 0.33, or 3.33%. See more

2.15 PM Jul 8th

Market Statistician

Platinum Member

10998 Followers

Aarey Drugs  

At 14:12 hrs, Aarey Drugs and Pharmaceuticals was trading at Rs 20.94 up 5.33%, with a huge increase in its volume of shares traded. Till now over 304,764 shares were traded as compared to its 5-day average of 114,854 shares.

2.15 PM Jul 8th

Market Statistician

Platinum Member

10998 Followers

Parenteral Drug  

At 14:13 hrs, Parenteral Drugs (India) was trading at Rs 35.20 up 8.64%, with a huge increase in its volume of shares traded. Till now over 392,958 shares were traded as compared to its 5-day average of 90,823 shares.

2.15 PM Jul 8th

madrasan

Silver Member

1 Followers

Shasun Pharma  

The company might be a beneficiary of the Sevelamer molecule drugs going off patent in the US. Shasun is expected to be one of the Active Pharmaceutical Ingredients (API) supplier of these drugs. The latest indication of these drugs going off patent is that one of the molecules Sevelamer Carbonate

12.48 PM Jul 8th

Market Statistician

Platinum Member

10998 Followers

Aarey Drugs  

At 12:14 hrs, Aarey Drugs and Pharmaceuticals was trading at Rs 20.83 up 4.78%, with a huge increase in its volume of shares traded. Till now over 256,745 shares were traded as compared to its 5-day average of 114,854 shares.

12.15 PM Jul 8th

Market Statistician

Platinum Member

10998 Followers

Parenteral Drug  

At 12:14 hrs, Parenteral Drugs (India) was trading at Rs 36.50 up 12.65%, with a huge increase in its volume of shares traded. Till now over 275,045 shares were traded as compared to its 5-day average of 90,823 shares.

12.15 PM Jul 8th

News across the web »
Nov 29, 2014 at 07:45 | Source: FirstPost
Nov 29, 2014 at 06:30 | Source: FirstPost
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.